SEC Form 4 · accession 0001354488-16-008214
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Myron Kaplan
Director
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2016 | P | 20,000 | $1.7248 | A | 20,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1 | $4.28 | holding | — | — | — | Apr 28, 2016 | Apr 28, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.
Remarks
M. Kaplan - Form 4